Blavatnik Len
SEC-identified person · CIK 1326628 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Digitalocean Holdings, Inc. DOCN | Officer | filed 2021 - 2026 |
| Hemab Therapeutics Holdings, Inc. COAG | Officer | filed 2026 - 2026 |
| Day One Biopharmaceuticals, Inc. DAWN | Officer | filed 2021 - 2026 |
| Warner Music Group Corp. wmg | Director | filed 2007 - 2026 |
| Reneo Pharmaceuticals, Inc. RPHM | Officer | filed 2026 - 2026 |
| Lyondellbasell Industries N.V. LYB | Officer | filed 2011 - 2026 |
| Zura Bio Ltd ZURA | Officer | filed 2025 - 2026 |
| Gemini Therapeutics, Inc. /DE IRON | Officer | filed 2023 - 2025 |
| Upstream Bio, Inc. UPB | Officer | filed 2024 - 2024 |
| Vyne Therapeutics Inc. VYNE | Officer | filed 2023 - 2023 |
| Verona Pharma plc VRNA | Officer | filed 2022 - 2022 |
| Gamida Cell Ltd. GMDA | Officer | filed 2022 - 2022 |
| Eliem Therapeutics, Inc. ELYM | Officer | filed 2021 - 2021 |
| Pandion Therapeutics, Inc. PAND | Officer | filed 2020 - 2020 |
| Neon Therapeutics, Inc. NTGN | Officer | filed 2018 - 2020 |
| Chemomab Therapeutics Ltd. CMMB | Officer | filed 2020 - 2020 |
| Square, Inc. XYZ | Officer | filed 2015 - 2015 |
| EP Energy Corp EPEGQ | Officer | filed 2014 - 2015 |
| Loxo Oncology, Inc. LOXO | Officer | filed 2014 - 2014 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.